nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—obesity	0.383	0.712	CbGaD
Naloxone—ESR1—obesity	0.107	0.2	CbGaD
Naloxone—ALB—obesity	0.0478	0.0889	CbGaD
Naloxone—CYP2C8—Bupropion—obesity	0.0402	0.219	CbGbCtD
Naloxone—CYP2C8—Cimetidine—obesity	0.0295	0.161	CbGbCtD
Naloxone—CYP3A4—Sibutramine—obesity	0.0253	0.138	CbGbCtD
Naloxone—ABCB1—Cimetidine—obesity	0.02	0.109	CbGbCtD
Naloxone—CYP3A4—Benzphetamine—obesity	0.0192	0.104	CbGbCtD
Naloxone—CYP3A4—Bupropion—obesity	0.0163	0.0888	CbGbCtD
Naloxone—CYP3A4—Orlistat—obesity	0.0133	0.0724	CbGbCtD
Naloxone—CYP3A4—Cimetidine—obesity	0.012	0.0652	CbGbCtD
Naloxone—CYP3A4—Topiramate—obesity	0.00784	0.0427	CbGbCtD
Naloxone—ESR1—ovarian follicle—obesity	0.00513	0.135	CbGeAlD
Naloxone—CREB1—hindbrain—obesity	0.00282	0.0741	CbGeAlD
Naloxone—Abdominal cramps—Phentermine—obesity	0.00281	0.0302	CcSEcCtD
Naloxone—TLR4—adipose tissue—obesity	0.00264	0.0694	CbGeAlD
Naloxone—TLR4—adrenal gland—obesity	0.00237	0.0623	CbGeAlD
Naloxone—Yawning—Sibutramine—obesity	0.00208	0.0224	CcSEcCtD
Naloxone—TLR4—liver—obesity	0.00185	0.0487	CbGeAlD
Naloxone—CREB1—islet of Langerhans—obesity	0.00182	0.0479	CbGeAlD
Naloxone—Yawning—Bupropion—obesity	0.00182	0.0195	CcSEcCtD
Naloxone—CREB1—respiratory system—obesity	0.00172	0.0453	CbGeAlD
Naloxone—Irritability—Phenylpropanolamine—obesity	0.00137	0.0147	CcSEcCtD
Naloxone—Sweating—Benzphetamine—obesity	0.00137	0.0147	CcSEcCtD
Naloxone—Sneezing—Bupropion—obesity	0.00132	0.0142	CcSEcCtD
Naloxone—CREB1—cardiovascular system—obesity	0.00132	0.0347	CbGeAlD
Naloxone—Cardiac arrest—Phentermine—obesity	0.00131	0.0141	CcSEcCtD
Naloxone—ALB—gall bladder—obesity	0.00128	0.0337	CbGeAlD
Naloxone—Sweating—Phendimetrazine—obesity	0.00124	0.0134	CcSEcCtD
Naloxone—CREB1—pituitary gland—obesity	0.00117	0.0307	CbGeAlD
Naloxone—CREB1—adipose tissue—obesity	0.00116	0.0306	CbGeAlD
Naloxone—ESR1—hindbrain—obesity	0.00111	0.0292	CbGeAlD
Naloxone—Ventricular fibrillation—Sibutramine—obesity	0.0011	0.0118	CcSEcCtD
Naloxone—CREB1—digestive system—obesity	0.00109	0.0288	CbGeAlD
Naloxone—Flushing—Phendimetrazine—obesity	0.00108	0.0116	CcSEcCtD
Naloxone—Tremor—Methamphetamine—obesity	0.00108	0.0116	CcSEcCtD
Naloxone—Agitation—Methamphetamine—obesity	0.00106	0.0114	CcSEcCtD
Naloxone—Tremor—Benzphetamine—obesity	0.00104	0.0112	CcSEcCtD
Naloxone—CREB1—adrenal gland—obesity	0.00104	0.0274	CbGeAlD
Naloxone—Agitation—Benzphetamine—obesity	0.00102	0.011	CcSEcCtD
Naloxone—Hallucination—Phenylpropanolamine—obesity	0.00099	0.0106	CcSEcCtD
Naloxone—Grand mal convulsion—Topiramate—obesity	0.000979	0.0105	CcSEcCtD
Naloxone—Tremor—Phendimetrazine—obesity	0.00095	0.0102	CcSEcCtD
Naloxone—Hallucination—Phentermine—obesity	0.000948	0.0102	CcSEcCtD
Naloxone—Agitation—Phendimetrazine—obesity	0.000932	0.01	CcSEcCtD
Naloxone—Flushing—Phenylpropanolamine—obesity	0.000924	0.00992	CcSEcCtD
Naloxone—Tachycardia—Methamphetamine—obesity	0.000919	0.00987	CcSEcCtD
Naloxone—CREB1—endocrine gland—obesity	0.000904	0.0238	CbGeAlD
Naloxone—Rhinorrhoea—Bupropion—obesity	0.000903	0.00969	CcSEcCtD
Naloxone—Tachycardia—Benzphetamine—obesity	0.000887	0.00952	CcSEcCtD
Naloxone—Hyperhidrosis—Benzphetamine—obesity	0.000878	0.00943	CcSEcCtD
Naloxone—Tension—Phenylpropanolamine—obesity	0.00085	0.00913	CcSEcCtD
Naloxone—Nervousness—Phenylpropanolamine—obesity	0.000842	0.00903	CcSEcCtD
Naloxone—Ventricular tachycardia—Sibutramine—obesity	0.000839	0.00901	CcSEcCtD
Naloxone—CREB1—liver—obesity	0.000815	0.0214	CbGeAlD
Naloxone—Tension—Phentermine—obesity	0.000814	0.00873	CcSEcCtD
Naloxone—Gastrointestinal disorder—Methamphetamine—obesity	0.000813	0.00873	CcSEcCtD
Naloxone—Tremor—Phenylpropanolamine—obesity	0.000812	0.00871	CcSEcCtD
Naloxone—Tachycardia—Phendimetrazine—obesity	0.000808	0.00867	CcSEcCtD
Naloxone—Nervousness—Phentermine—obesity	0.000805	0.00864	CcSEcCtD
Naloxone—Hyperhidrosis—Phendimetrazine—obesity	0.0008	0.00859	CcSEcCtD
Naloxone—Agitation—Phenylpropanolamine—obesity	0.000796	0.00855	CcSEcCtD
Naloxone—Hallucination—Cimetidine—obesity	0.000785	0.00842	CcSEcCtD
Naloxone—Gastrointestinal disorder—Benzphetamine—obesity	0.000784	0.00842	CcSEcCtD
Naloxone—Tremor—Phentermine—obesity	0.000777	0.00834	CcSEcCtD
Naloxone—Agitation—Phentermine—obesity	0.000762	0.00818	CcSEcCtD
Naloxone—Hyperkinesia—Sibutramine—obesity	0.000732	0.00785	CcSEcCtD
Naloxone—Encephalopathy—Topiramate—obesity	0.000726	0.00779	CcSEcCtD
Naloxone—Hypertension—Phentermine—obesity	0.000716	0.00768	CcSEcCtD
Naloxone—Tension—Diethylpropion—obesity	0.000708	0.0076	CcSEcCtD
Naloxone—Nervousness—Diethylpropion—obesity	0.000701	0.00752	CcSEcCtD
Naloxone—Tachycardia—Phenylpropanolamine—obesity	0.00069	0.00741	CcSEcCtD
Naloxone—ESR1—respiratory system—obesity	0.000677	0.0178	CbGeAlD
Naloxone—Tremor—Diethylpropion—obesity	0.000676	0.00725	CcSEcCtD
Naloxone—Coma—Bupropion—obesity	0.000668	0.00717	CcSEcCtD
Naloxone—Menopausal symptoms—Orlistat—obesity	0.000667	0.00716	CcSEcCtD
Naloxone—Agitation—Diethylpropion—obesity	0.000663	0.00712	CcSEcCtD
Naloxone—Tachycardia—Phentermine—obesity	0.000661	0.00709	CcSEcCtD
Naloxone—Abdominal pain—Phendimetrazine—obesity	0.000654	0.00702	CcSEcCtD
Naloxone—Diarrhoea—Methamphetamine—obesity	0.000645	0.00692	CcSEcCtD
Naloxone—Hyperkinesia—Bupropion—obesity	0.000638	0.00685	CcSEcCtD
Naloxone—Agitation—Cimetidine—obesity	0.000631	0.00677	CcSEcCtD
Naloxone—Dyspnoea—Phenylpropanolamine—obesity	0.000631	0.00677	CcSEcCtD
Naloxone—Convulsion—Diethylpropion—obesity	0.000625	0.00671	CcSEcCtD
Naloxone—Diarrhoea—Benzphetamine—obesity	0.000621	0.00667	CcSEcCtD
Naloxone—Gastrointestinal disorder—Phentermine—obesity	0.000584	0.00627	CcSEcCtD
Naloxone—Cardiac arrest—Sibutramine—obesity	0.000579	0.00622	CcSEcCtD
Naloxone—Rhinorrhoea—Topiramate—obesity	0.000575	0.00617	CcSEcCtD
Naloxone—Tachycardia—Diethylpropion—obesity	0.000575	0.00617	CcSEcCtD
Naloxone—Hyperhidrosis—Diethylpropion—obesity	0.000569	0.00611	CcSEcCtD
Naloxone—Hot flush—Bupropion—obesity	0.000568	0.00609	CcSEcCtD
Naloxone—Diarrhoea—Phendimetrazine—obesity	0.000566	0.00608	CcSEcCtD
Naloxone—Menopausal symptoms—Bupropion—obesity	0.000563	0.00604	CcSEcCtD
Naloxone—Tachycardia—Cimetidine—obesity	0.000547	0.00587	CcSEcCtD
Naloxone—Nausea—Benzphetamine—obesity	0.00054	0.00579	CcSEcCtD
Naloxone—Abdominal pain—Phentermine—obesity	0.000535	0.00574	CcSEcCtD
Naloxone—Dyspnoea—Diethylpropion—obesity	0.000525	0.00563	CcSEcCtD
Naloxone—ESR1—cardiovascular system—obesity	0.000519	0.0136	CbGeAlD
Naloxone—Gastrointestinal disorder—Diethylpropion—obesity	0.000508	0.00546	CcSEcCtD
Naloxone—SLCO1A2—digestive system—obesity	0.000508	0.0134	CbGeAlD
Naloxone—Irritability—Bupropion—obesity	0.000507	0.00544	CcSEcCtD
Naloxone—Nausea—Phendimetrazine—obesity	0.000492	0.00528	CcSEcCtD
Naloxone—OPRM1—endocrine gland—obesity	0.000487	0.0128	CbGeAlD
Naloxone—Asthenia—Phentermine—obesity	0.000486	0.00521	CcSEcCtD
Naloxone—Depression—Orlistat—obesity	0.000484	0.00519	CcSEcCtD
Naloxone—ALB—adrenal gland—obesity	0.000481	0.0127	CbGeAlD
Naloxone—Nasopharyngitis—Bupropion—obesity	0.000475	0.0051	CcSEcCtD
Naloxone—Depression—Sibutramine—obesity	0.000468	0.00502	CcSEcCtD
Naloxone—Diarrhoea—Phentermine—obesity	0.000463	0.00497	CcSEcCtD
Naloxone—ESR1—pituitary gland—obesity	0.000459	0.0121	CbGeAlD
Naloxone—ESR1—adipose tissue—obesity	0.000457	0.012	CbGeAlD
Naloxone—Sweating—Sibutramine—obesity	0.00045	0.00483	CcSEcCtD
Naloxone—Vomiting—Phenylpropanolamine—obesity	0.00045	0.00483	CcSEcCtD
Naloxone—Body temperature increased—Cimetidine—obesity	0.000443	0.00475	CcSEcCtD
Naloxone—ESR1—digestive system—obesity	0.00043	0.0113	CbGeAlD
Naloxone—Vomiting—Phentermine—obesity	0.00043	0.00462	CcSEcCtD
Naloxone—Nausea—Phenylpropanolamine—obesity	0.00042	0.00451	CcSEcCtD
Naloxone—SLCO1A2—endocrine gland—obesity	0.000419	0.011	CbGeAlD
Naloxone—ESR1—adrenal gland—obesity	0.00041	0.0108	CbGeAlD
Naloxone—Hyperkinesia—Topiramate—obesity	0.000406	0.00436	CcSEcCtD
Naloxone—Diarrhoea—Diethylpropion—obesity	0.000403	0.00432	CcSEcCtD
Naloxone—Nausea—Phentermine—obesity	0.000402	0.00431	CcSEcCtD
Naloxone—Asthenia—Cimetidine—obesity	0.000402	0.00431	CcSEcCtD
Naloxone—Mediastinal disorder—Orlistat—obesity	0.000392	0.00421	CcSEcCtD
Naloxone—Sweating—Bupropion—obesity	0.000392	0.00421	CcSEcCtD
Naloxone—Diarrhoea—Cimetidine—obesity	0.000383	0.00411	CcSEcCtD
Naloxone—Angiopathy—Sibutramine—obesity	0.000382	0.0041	CcSEcCtD
Naloxone—Mental disorder—Orlistat—obesity	0.000381	0.00409	CcSEcCtD
Naloxone—CYP2C8—pituitary gland—obesity	0.000378	0.00995	CbGeAlD
Naloxone—SLCO1A2—liver—obesity	0.000378	0.00995	CbGeAlD
Naloxone—Chills—Sibutramine—obesity	0.000378	0.00406	CcSEcCtD
Naloxone—ALB—liver—obesity	0.000376	0.00989	CbGeAlD
Naloxone—Vomiting—Diethylpropion—obesity	0.000374	0.00402	CcSEcCtD
Naloxone—Hallucination—Bupropion—obesity	0.000365	0.00392	CcSEcCtD
Naloxone—Hot flush—Topiramate—obesity	0.000362	0.00388	CcSEcCtD
Naloxone—Tension—Sibutramine—obesity	0.00036	0.00386	CcSEcCtD
Naloxone—Menopausal symptoms—Topiramate—obesity	0.000358	0.00385	CcSEcCtD
Naloxone—Nervousness—Sibutramine—obesity	0.000356	0.00382	CcSEcCtD
Naloxone—Vomiting—Cimetidine—obesity	0.000356	0.00382	CcSEcCtD
Naloxone—ESR1—endocrine gland—obesity	0.000356	0.00936	CbGeAlD
Naloxone—Nausea—Diethylpropion—obesity	0.00035	0.00375	CcSEcCtD
Naloxone—Tremor—Sibutramine—obesity	0.000344	0.00369	CcSEcCtD
Naloxone—Cardiac disorder—Bupropion—obesity	0.000341	0.00366	CcSEcCtD
Naloxone—Flushing—Bupropion—obesity	0.000341	0.00366	CcSEcCtD
Naloxone—Agitation—Sibutramine—obesity	0.000337	0.00362	CcSEcCtD
Naloxone—Angiopathy—Bupropion—obesity	0.000333	0.00358	CcSEcCtD
Naloxone—Nausea—Cimetidine—obesity	0.000333	0.00357	CcSEcCtD
Naloxone—Mediastinal disorder—Bupropion—obesity	0.000331	0.00355	CcSEcCtD
Naloxone—Chills—Bupropion—obesity	0.00033	0.00354	CcSEcCtD
Naloxone—Convulsion—Orlistat—obesity	0.000328	0.00352	CcSEcCtD
Naloxone—Irritability—Topiramate—obesity	0.000323	0.00347	CcSEcCtD
Naloxone—Mental disorder—Bupropion—obesity	0.000322	0.00345	CcSEcCtD
Naloxone—ESR1—liver—obesity	0.000321	0.00844	CbGeAlD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00032	0.00344	CcSEcCtD
Naloxone—Convulsion—Sibutramine—obesity	0.000318	0.00341	CcSEcCtD
Naloxone—Hypertension—Sibutramine—obesity	0.000317	0.0034	CcSEcCtD
Naloxone—Tension—Bupropion—obesity	0.000314	0.00337	CcSEcCtD
Naloxone—Nervousness—Bupropion—obesity	0.000311	0.00333	CcSEcCtD
Naloxone—Nervous system disorder—Orlistat—obesity	0.000303	0.00326	CcSEcCtD
Naloxone—Nasopharyngitis—Topiramate—obesity	0.000302	0.00325	CcSEcCtD
Naloxone—Skin disorder—Orlistat—obesity	0.0003	0.00322	CcSEcCtD
Naloxone—Tremor—Bupropion—obesity	0.0003	0.00322	CcSEcCtD
Naloxone—Hyperhidrosis—Orlistat—obesity	0.000299	0.00321	CcSEcCtD
Naloxone—Agitation—Bupropion—obesity	0.000294	0.00315	CcSEcCtD
Naloxone—CYP2C8—endocrine gland—obesity	0.000293	0.00771	CbGeAlD
Naloxone—Tachycardia—Sibutramine—obesity	0.000292	0.00314	CcSEcCtD
Naloxone—Skin disorder—Sibutramine—obesity	0.000291	0.00312	CcSEcCtD
Naloxone—Hyperhidrosis—Sibutramine—obesity	0.000289	0.00311	CcSEcCtD
Naloxone—ABCB1—islet of Langerhans—obesity	0.000283	0.00745	CbGeAlD
Naloxone—Paraesthesia—Orlistat—obesity	0.000278	0.00298	CcSEcCtD
Naloxone—Convulsion—Bupropion—obesity	0.000277	0.00297	CcSEcCtD
Naloxone—Hypertension—Bupropion—obesity	0.000276	0.00296	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00027	0.0029	CcSEcCtD
Naloxone—Paraesthesia—Sibutramine—obesity	0.000269	0.00288	CcSEcCtD
Naloxone—ABCB1—respiratory system—obesity	0.000267	0.00704	CbGeAlD
Naloxone—Gastrointestinal disorder—Orlistat—obesity	0.000267	0.00287	CcSEcCtD
Naloxone—Dyspnoea—Sibutramine—obesity	0.000267	0.00286	CcSEcCtD
Naloxone—Pain—Orlistat—obesity	0.000264	0.00284	CcSEcCtD
Naloxone—CYP2C8—liver—obesity	0.000264	0.00695	CbGeAlD
Naloxone—Depression—Topiramate—obesity	0.00026	0.00279	CcSEcCtD
Naloxone—Gastrointestinal disorder—Sibutramine—obesity	0.000258	0.00277	CcSEcCtD
Naloxone—Pain—Sibutramine—obesity	0.000256	0.00275	CcSEcCtD
Naloxone—Nervous system disorder—Bupropion—obesity	0.000256	0.00275	CcSEcCtD
Naloxone—Tachycardia—Bupropion—obesity	0.000255	0.00273	CcSEcCtD
Naloxone—Skin disorder—Bupropion—obesity	0.000253	0.00272	CcSEcCtD
Naloxone—Hyperhidrosis—Bupropion—obesity	0.000252	0.00271	CcSEcCtD
Naloxone—Abdominal pain—Orlistat—obesity	0.000244	0.00262	CcSEcCtD
Naloxone—Body temperature increased—Orlistat—obesity	0.000244	0.00262	CcSEcCtD
Naloxone—CYP3A4—digestive system—obesity	0.00024	0.00632	CbGeAlD
Naloxone—Abdominal pain—Sibutramine—obesity	0.000237	0.00254	CcSEcCtD
Naloxone—Body temperature increased—Sibutramine—obesity	0.000237	0.00254	CcSEcCtD
Naloxone—Paraesthesia—Bupropion—obesity	0.000234	0.00251	CcSEcCtD
Naloxone—Hallucination—Topiramate—obesity	0.000233	0.0025	CcSEcCtD
Naloxone—Dyspnoea—Bupropion—obesity	0.000233	0.0025	CcSEcCtD
Naloxone—Gastrointestinal disorder—Bupropion—obesity	0.000225	0.00242	CcSEcCtD
Naloxone—ABCB1—adrenal cortex—obesity	0.000224	0.00591	CbGeAlD
Naloxone—Pain—Bupropion—obesity	0.000223	0.0024	CcSEcCtD
Naloxone—Asthenia—Orlistat—obesity	0.000222	0.00238	CcSEcCtD
Naloxone—Cardiac disorder—Topiramate—obesity	0.000217	0.00233	CcSEcCtD
Naloxone—Flushing—Topiramate—obesity	0.000217	0.00233	CcSEcCtD
Naloxone—Asthenia—Sibutramine—obesity	0.000215	0.00231	CcSEcCtD
Naloxone—Angiopathy—Topiramate—obesity	0.000212	0.00228	CcSEcCtD
Naloxone—Diarrhoea—Orlistat—obesity	0.000212	0.00227	CcSEcCtD
Naloxone—Mediastinal disorder—Topiramate—obesity	0.000211	0.00226	CcSEcCtD
Naloxone—Chills—Topiramate—obesity	0.00021	0.00225	CcSEcCtD
Naloxone—Body temperature increased—Bupropion—obesity	0.000206	0.00221	CcSEcCtD
Naloxone—Abdominal pain—Bupropion—obesity	0.000206	0.00221	CcSEcCtD
Naloxone—Mental disorder—Topiramate—obesity	0.000205	0.0022	CcSEcCtD
Naloxone—ABCB1—cardiovascular system—obesity	0.000205	0.00539	CbGeAlD
Naloxone—Diarrhoea—Sibutramine—obesity	0.000205	0.0022	CcSEcCtD
Naloxone—Tension—Topiramate—obesity	0.0002	0.00215	CcSEcCtD
Naloxone—CYP3A4—endocrine gland—obesity	0.000198	0.00522	CbGeAlD
Naloxone—Nervousness—Topiramate—obesity	0.000198	0.00212	CcSEcCtD
Naloxone—Vomiting—Orlistat—obesity	0.000197	0.00211	CcSEcCtD
Naloxone—Tremor—Topiramate—obesity	0.000191	0.00205	CcSEcCtD
Naloxone—Vomiting—Sibutramine—obesity	0.00019	0.00204	CcSEcCtD
Naloxone—Asthenia—Bupropion—obesity	0.000187	0.00201	CcSEcCtD
Naloxone—Agitation—Topiramate—obesity	0.000187	0.00201	CcSEcCtD
Naloxone—Nausea—Orlistat—obesity	0.000184	0.00197	CcSEcCtD
Naloxone—ABCB1—pituitary gland—obesity	0.000181	0.00477	CbGeAlD
Naloxone—ABCB1—adipose tissue—obesity	0.000181	0.00475	CbGeAlD
Naloxone—CYP3A4—liver—obesity	0.000179	0.00471	CbGeAlD
Naloxone—Diarrhoea—Bupropion—obesity	0.000179	0.00192	CcSEcCtD
Naloxone—Nausea—Sibutramine—obesity	0.000178	0.00191	CcSEcCtD
Naloxone—Convulsion—Topiramate—obesity	0.000176	0.00189	CcSEcCtD
Naloxone—Hypertension—Topiramate—obesity	0.000176	0.00189	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000172	0.00185	CcSEcCtD
Naloxone—ABCB1—digestive system—obesity	0.00017	0.00447	CbGeAlD
Naloxone—Vomiting—Bupropion—obesity	0.000166	0.00178	CcSEcCtD
Naloxone—Nervous system disorder—Topiramate—obesity	0.000163	0.00175	CcSEcCtD
Naloxone—Tachycardia—Topiramate—obesity	0.000162	0.00174	CcSEcCtD
Naloxone—ABCB1—adrenal gland—obesity	0.000162	0.00426	CbGeAlD
Naloxone—Skin disorder—Topiramate—obesity	0.000161	0.00173	CcSEcCtD
Naloxone—Hyperhidrosis—Topiramate—obesity	0.000161	0.00173	CcSEcCtD
Naloxone—Nausea—Bupropion—obesity	0.000155	0.00166	CcSEcCtD
Naloxone—Paraesthesia—Topiramate—obesity	0.000149	0.0016	CcSEcCtD
Naloxone—Dyspnoea—Topiramate—obesity	0.000148	0.00159	CcSEcCtD
Naloxone—Gastrointestinal disorder—Topiramate—obesity	0.000144	0.00154	CcSEcCtD
Naloxone—Pain—Topiramate—obesity	0.000142	0.00153	CcSEcCtD
Naloxone—ABCB1—endocrine gland—obesity	0.00014	0.0037	CbGeAlD
Naloxone—Body temperature increased—Topiramate—obesity	0.000131	0.00141	CcSEcCtD
Naloxone—Abdominal pain—Topiramate—obesity	0.000131	0.00141	CcSEcCtD
Naloxone—ABCB1—liver—obesity	0.000127	0.00333	CbGeAlD
Naloxone—Asthenia—Topiramate—obesity	0.000119	0.00128	CcSEcCtD
Naloxone—Diarrhoea—Topiramate—obesity	0.000114	0.00122	CcSEcCtD
Naloxone—Vomiting—Topiramate—obesity	0.000106	0.00113	CcSEcCtD
Naloxone—Nausea—Topiramate—obesity	9.87e-05	0.00106	CcSEcCtD
Naloxone—ESR1—Signaling Pathways—APOA1—obesity	2.63e-06	1.79e-05	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AKT1—obesity	2.6e-06	1.77e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—POMC—obesity	2.57e-06	1.76e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—COMT—obesity	2.56e-06	1.75e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—obesity	2.56e-06	1.75e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—INS—obesity	2.56e-06	1.75e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GCG—obesity	2.56e-06	1.74e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC2A4—obesity	2.56e-06	1.74e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—obesity	2.55e-06	1.74e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—COMT—obesity	2.55e-06	1.74e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—LPA—obesity	2.55e-06	1.74e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PIK3CA—obesity	2.53e-06	1.73e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNB3—obesity	2.53e-06	1.72e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPARGC1A—obesity	2.53e-06	1.72e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYCS—obesity	2.52e-06	1.72e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL2—obesity	2.52e-06	1.72e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—HMOX1—obesity	2.52e-06	1.72e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPARGC1A—obesity	2.51e-06	1.71e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNB3—obesity	2.51e-06	1.71e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—F2—obesity	2.51e-06	1.71e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PRKCB—obesity	2.51e-06	1.71e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—HMOX1—obesity	2.5e-06	1.71e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—LPIN1—obesity	2.49e-06	1.7e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IGF1—obesity	2.48e-06	1.69e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—BAD—obesity	2.48e-06	1.69e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GOT1—obesity	2.48e-06	1.69e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GGT1—obesity	2.48e-06	1.69e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKT2—obesity	2.47e-06	1.69e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNAS—obesity	2.46e-06	1.68e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MTOR—obesity	2.45e-06	1.67e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PIK3CB—obesity	2.45e-06	1.67e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNAS—obesity	2.45e-06	1.67e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOA5—obesity	2.44e-06	1.67e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—PIK3CA—obesity	2.44e-06	1.67e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NCOA1—obesity	2.44e-06	1.66e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—obesity	2.44e-06	1.66e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—obesity	2.43e-06	1.66e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOB—obesity	2.41e-06	1.64e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—STK11—obesity	2.4e-06	1.64e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP19A1—obesity	2.4e-06	1.64e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3CG—obesity	2.4e-06	1.63e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOB—obesity	2.4e-06	1.63e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PIK3CD—obesity	2.38e-06	1.62e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MAPK8—obesity	2.37e-06	1.62e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IRS1—obesity	2.37e-06	1.62e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AKT1—obesity	2.36e-06	1.61e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MAPK8—obesity	2.36e-06	1.61e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AKT1—obesity	2.36e-06	1.61e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—PIK3CA—obesity	2.35e-06	1.61e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SERPINE1—obesity	2.35e-06	1.6e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—obesity	2.34e-06	1.6e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—obesity	2.34e-06	1.6e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CLOCK—obesity	2.33e-06	1.59e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC22A1—obesity	2.33e-06	1.59e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—LPL—obesity	2.3e-06	1.57e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—LPL—obesity	2.29e-06	1.56e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TYK2—obesity	2.29e-06	1.56e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—POMC—obesity	2.28e-06	1.56e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AKT1—obesity	2.28e-06	1.55e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SULT2A1—obesity	2.27e-06	1.55e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GLP1R—obesity	2.27e-06	1.55e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—INS—obesity	2.27e-06	1.55e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RHOA—obesity	2.27e-06	1.55e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GPX1—obesity	2.25e-06	1.53e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PIK3R1—obesity	2.24e-06	1.53e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOS3—obesity	2.24e-06	1.53e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—obesity	2.24e-06	1.53e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DPYD—obesity	2.23e-06	1.52e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—COMT—obesity	2.23e-06	1.52e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GPX1—obesity	2.23e-06	1.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL2—obesity	2.23e-06	1.52e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNB3—obesity	2.2e-06	1.5e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPARGC1A—obesity	2.2e-06	1.5e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IGF1—obesity	2.2e-06	1.5e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT2—obesity	2.19e-06	1.5e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—HMOX1—obesity	2.19e-06	1.5e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CD36—obesity	2.19e-06	1.49e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CD36—obesity	2.17e-06	1.48e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—STAT3—obesity	2.17e-06	1.48e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—obesity	2.16e-06	1.47e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—STAT3—obesity	2.16e-06	1.47e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—AKT1—obesity	2.16e-06	1.47e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PRKAR2B—obesity	2.15e-06	1.47e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNAS—obesity	2.14e-06	1.46e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PIK3CA—obesity	2.14e-06	1.46e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DCN—obesity	2.14e-06	1.46e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—obesity	2.13e-06	1.45e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3CD—obesity	2.11e-06	1.44e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOB—obesity	2.1e-06	1.43e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SERPINE1—obesity	2.08e-06	1.42e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CPT1A—obesity	2.08e-06	1.42e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MTHFR—obesity	2.07e-06	1.41e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MAPK8—obesity	2.07e-06	1.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PIK3CB—obesity	2.07e-06	1.41e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MTOR—obesity	2.07e-06	1.41e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AKT1—obesity	2.07e-06	1.41e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—MTHFR—obesity	2.06e-06	1.41e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NAMPT—obesity	2.04e-06	1.39e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPARA—obesity	2.03e-06	1.39e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—obesity	2.03e-06	1.38e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TYK2—obesity	2.03e-06	1.38e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GCK—obesity	2.02e-06	1.38e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—LIPC—obesity	2.02e-06	1.38e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPARA—obesity	2.02e-06	1.38e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—obesity	2.01e-06	1.37e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOC3—obesity	2.01e-06	1.37e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RHOA—obesity	2.01e-06	1.37e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—obesity	2.01e-06	1.37e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—obesity	2.01e-06	1.37e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—LPL—obesity	2.01e-06	1.37e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—obesity	2e-06	1.37e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PIK3CA—obesity	1.99e-06	1.36e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—AKT1—obesity	1.99e-06	1.36e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3R1—obesity	1.99e-06	1.36e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOS3—obesity	1.99e-06	1.36e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AGT—obesity	1.97e-06	1.34e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—AGT—obesity	1.96e-06	1.34e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GPX1—obesity	1.96e-06	1.33e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CETP—obesity	1.95e-06	1.33e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SDC1—obesity	1.93e-06	1.32e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOE—obesity	1.93e-06	1.32e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AKT1—obesity	1.92e-06	1.31e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOE—obesity	1.92e-06	1.31e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CAV1—obesity	1.91e-06	1.3e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOA1—obesity	1.91e-06	1.3e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CD36—obesity	1.91e-06	1.3e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CAV1—obesity	1.9e-06	1.3e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKR1C3—obesity	1.9e-06	1.3e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOA1—obesity	1.9e-06	1.29e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—STAT3—obesity	1.89e-06	1.29e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—obesity	1.89e-06	1.29e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SCARB1—obesity	1.87e-06	1.28e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3CB—obesity	1.84e-06	1.25e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MTOR—obesity	1.84e-06	1.25e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.83e-06	1.25e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.82e-06	1.24e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SREBF1—obesity	1.82e-06	1.24e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MTHFR—obesity	1.81e-06	1.23e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—obesity	1.8e-06	1.23e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPARA—obesity	1.77e-06	1.21e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GOT2—obesity	1.77e-06	1.2e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—obesity	1.76e-06	1.2e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—obesity	1.76e-06	1.2e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MAPK8—obesity	1.75e-06	1.19e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AKT1—obesity	1.75e-06	1.19e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3CG—obesity	1.74e-06	1.19e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3CG—obesity	1.73e-06	1.18e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—FASN—obesity	1.73e-06	1.18e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—BCHE—obesity	1.72e-06	1.17e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AGT—obesity	1.72e-06	1.17e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PIK3CA—obesity	1.71e-06	1.17e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PIK3CA—obesity	1.7e-06	1.16e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOE—obesity	1.68e-06	1.15e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPARG—obesity	1.68e-06	1.15e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPARG—obesity	1.67e-06	1.14e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CAV1—obesity	1.67e-06	1.14e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOA1—obesity	1.66e-06	1.13e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP2E1—obesity	1.66e-06	1.13e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—POMC—obesity	1.66e-06	1.13e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PIK3CA—obesity	1.66e-06	1.13e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—INS—obesity	1.65e-06	1.12e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—POMC—obesity	1.65e-06	1.12e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NQO1—obesity	1.64e-06	1.12e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—INS—obesity	1.64e-06	1.12e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—AKT1—obesity	1.63e-06	1.11e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—STAT3—obesity	1.6e-06	1.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—obesity	1.6e-06	1.09e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC2A4—obesity	1.57e-06	1.07e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GCG—obesity	1.57e-06	1.07e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYCS—obesity	1.55e-06	1.06e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MAPK8—obesity	1.55e-06	1.06e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3CD—obesity	1.53e-06	1.04e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GOT1—obesity	1.53e-06	1.04e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GGT1—obesity	1.53e-06	1.04e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3CD—obesity	1.52e-06	1.04e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3CG—obesity	1.52e-06	1.03e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—obesity	1.51e-06	1.03e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALB—obesity	1.51e-06	1.03e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—obesity	1.51e-06	1.03e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NCOA1—obesity	1.5e-06	1.02e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PIK3CA—obesity	1.49e-06	1.02e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—obesity	1.49e-06	1.01e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—obesity	1.48e-06	1.01e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—STK11—obesity	1.48e-06	1.01e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP19A1—obesity	1.48e-06	1.01e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPARG—obesity	1.46e-06	9.98e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—NOS3—obesity	1.45e-06	9.86e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3R1—obesity	1.45e-06	9.86e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—POMC—obesity	1.44e-06	9.85e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3R1—obesity	1.44e-06	9.8e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—NOS3—obesity	1.44e-06	9.8e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—INS—obesity	1.44e-06	9.79e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STAT3—obesity	1.42e-06	9.68e-06	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—AKT1—obesity	1.41e-06	9.6e-06	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKT1—obesity	1.4e-06	9.53e-06	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKT1—obesity	1.39e-06	9.49e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—COMT—obesity	1.38e-06	9.39e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPARGC1A—obesity	1.36e-06	9.25e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNB3—obesity	1.36e-06	9.25e-06	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AKT1—obesity	1.35e-06	9.22e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—HMOX1—obesity	1.35e-06	9.21e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3CB—obesity	1.33e-06	9.1e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3CD—obesity	1.33e-06	9.09e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3CB—obesity	1.33e-06	9.05e-06	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—obesity	1.32e-06	9.02e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—obesity	1.32e-06	9.02e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNAS—obesity	1.32e-06	9.01e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—obesity	1.32e-06	9e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALB—obesity	1.32e-06	8.98e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—obesity	1.32e-06	8.97e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—obesity	1.31e-06	8.96e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOB—obesity	1.29e-06	8.82e-06	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PIK3CA—obesity	1.26e-06	8.61e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3R1—obesity	1.26e-06	8.59e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—NOS3—obesity	1.26e-06	8.59e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—LPL—obesity	1.24e-06	8.43e-06	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKT1—obesity	1.22e-06	8.33e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GPX1—obesity	1.21e-06	8.22e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CD36—obesity	1.17e-06	8.01e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3CB—obesity	1.16e-06	7.93e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—obesity	1.15e-06	7.85e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3CA—obesity	1.12e-06	7.64e-06	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—obesity	1.12e-06	7.63e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MTHFR—obesity	1.11e-06	7.59e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPARA—obesity	1.09e-06	7.44e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AGT—obesity	1.06e-06	7.21e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOE—obesity	1.04e-06	7.06e-06	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKT1—obesity	1.03e-06	7.04e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CAV1—obesity	1.03e-06	7e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOA1—obesity	1.02e-06	6.98e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—obesity	9.92e-07	6.76e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3CG—obesity	9.35e-07	6.37e-06	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT1—obesity	9.15e-07	6.24e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPARG—obesity	9.02e-07	6.15e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—POMC—obesity	8.9e-07	6.07e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—INS—obesity	8.85e-07	6.03e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3CD—obesity	8.22e-07	5.6e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3CA—obesity	8.13e-07	5.55e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALB—obesity	8.11e-07	5.53e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3CA—obesity	8.09e-07	5.52e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3R1—obesity	7.76e-07	5.29e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—NOS3—obesity	7.76e-07	5.29e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3CB—obesity	7.16e-07	4.88e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—obesity	7.1e-07	4.84e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3CA—obesity	7.09e-07	4.83e-06	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AKT1—obesity	6.65e-07	4.53e-06	CbGpPWpGaD
Naloxone—ALB—Metabolism—AKT1—obesity	6.61e-07	4.51e-06	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AKT1—obesity	5.79e-07	3.95e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3CA—obesity	4.37e-07	2.98e-06	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKT1—obesity	3.57e-07	2.43e-06	CbGpPWpGaD
